Salmonella as a vaccine delivery vehicle
- PMID: 24053397
- PMCID: PMC3956298
- DOI: 10.1586/14760584.2013.825454
Salmonella as a vaccine delivery vehicle
Erratum in
- Expert Rev Vaccines. 2014 Mar;13(3):443
Abstract
Attenuated Salmonella vaccines can be administered orally to deliver recombinant antigens to mucosal surfaces inducing a protective immune response against a variety of targeted pathogens. A number of exciting new approaches and technologies for attenuated Salmonella vaccines have been developed recently. However, a disconnect remains between results obtained with mice in preclinical studies and results obtained in human clinical trials. This is due to an incomplete understanding of Salmonella Typhi interactions with human hosts and inadequate animal models available for study. In this review, the authors describe recent progress in identifying important differences underlying S. Typhi-host interactions, the development of novel approaches to vaccine design and six recent clinical trials evaluating Salmonella-vectored vaccines.
Similar articles
-
Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors.Vaccine. 2003 Jan 17;21(5-6):401-18. doi: 10.1016/s0264-410x(02)00472-3. Vaccine. 2003. PMID: 12531639 Review.
-
Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost.J Immunol. 2009 Jan 15;182(2):1211-22. doi: 10.4049/jimmunol.182.2.1211. J Immunol. 2009. PMID: 19124765 Free PMC article.
-
Rational design of Salmonella recombinant vaccines.Int J Med Microbiol. 2008 Jan;298(1-2):87-98. doi: 10.1016/j.ijmm.2007.08.006. Epub 2007 Sep 20. Int J Med Microbiol. 2008. PMID: 17888730 Review.
-
A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.Vaccine. 2013 Oct 1;31(42):4874-80. doi: 10.1016/j.vaccine.2013.07.049. Epub 2013 Aug 3. Vaccine. 2013. PMID: 23916987 Clinical Trial.
-
Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.Vaccine. 2004 Jun 2;22(17-18):2273-7. doi: 10.1016/j.vaccine.2003.11.020. Vaccine. 2004. PMID: 15149786 Clinical Trial.
Cited by
-
Intracellular Survival and Pathogenicity Modulation of Salmonella Lon, CpxR, and RfaL Mutants Used as Live Bacterial Vectors under Abiotic Stress, Unveiling the Link between Stress Response and Virulence in Epithelial Cells.Int J Mol Sci. 2024 Aug 21;25(16):9056. doi: 10.3390/ijms25169056. Int J Mol Sci. 2024. PMID: 39201742 Free PMC article.
-
Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy.J Cancer. 2019 Aug 20;10(20):4765-4776. doi: 10.7150/jca.32650. eCollection 2019. J Cancer. 2019. PMID: 31598148 Free PMC article. Review.
-
Multicopy integration of mini-Tn7 transposons into selected chromosomal sites of a Salmonella vaccine strain.Microb Biotechnol. 2015 Jan;8(1):177-87. doi: 10.1111/1751-7915.12187. Epub 2014 Dec 9. Microb Biotechnol. 2015. PMID: 25488129 Free PMC article.
-
Oral immunization of rat with chromosomal expression LipL32 in attenuated Salmonella vaccine induces immune respond against pathogenic Leptospira.Clin Exp Vaccine Res. 2021 Sep;10(3):217-228. doi: 10.7774/cevr.2021.10.3.217. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703804 Free PMC article.
-
Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge.Vet Res. 2020 Jan 23;51(1):6. doi: 10.1186/s13567-020-0735-y. Vet Res. 2020. PMID: 31973749 Free PMC article.
References
-
- Pasetti MF, Levine MM, Sztein MB. Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors. Vaccine. 2003;21(5–6):401–418. - PubMed
Websites
-
- IL-2 expressing attenuated Salmonella Typhimurium in unresectable hepatic spread. [accessed March 7, 2013]; http://www.clinicaltrials.gov/ct2/show/NCT01099631?term=salmonella+cance....
-
- Recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae PspA. [accessed March 7, 2013]; http://www.clinicaltrials.gov/ct2/show/NCT01033409?term=salmonella+pneum.... - PubMed
-
- Safety and immunogenicity of CVD 1902 oral attenuated vaccine to prevent S. Paratyphi A infection. [accessed March 7, 2013]; http://www.clinicaltrials.gov/ct2/show/NCT01129453?term=paratyphi+a&rank=1.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical